Scienture Holdings [SCNX] vs Walgreens Boots [WBA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Scienture Holdings Inc. wins in 11 metrics, Walgreens Boots Alliance Inc. wins in 9 metrics, with 0 ties. Scienture Holdings Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Scienture Holdings Inc. | Walgreens Boots Alliance Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.56 | 27.10 | Scienture Holdings Inc. |
| Price-to-Book Ratio | 0.24 | 1.44 | Scienture Holdings Inc. |
| Debt-to-Equity Ratio | 0.03 | 409.88 | Scienture Holdings Inc. |
| PEG Ratio | -1.99 | -0.18 | Walgreens Boots Alliance Inc. |
| EV/EBITDA | -0.66 | 13.10 | Walgreens Boots Alliance Inc. |
| Profit Margin (TTM) | 76.80% | -4.07% | Scienture Holdings Inc. |
| Operating Margin (TTM) | 1,869.82% | 0.74% | Scienture Holdings Inc. |
| EBITDA Margin (TTM) | 1,869.82% | 0.74% | Scienture Holdings Inc. |
| Return on Equity | -55.65% | -69.58% | Scienture Holdings Inc. |
| Return on Assets (TTM) | -10.74% | 0.83% | Walgreens Boots Alliance Inc. |
| Free Cash Flow (TTM) | $-13.38M | $-363.00M | Scienture Holdings Inc. |
| Dividend Yield | 151.52% | 4.39% | Scienture Holdings Inc. |
| 1-Year Return | -64.49% | 29.51% | Walgreens Boots Alliance Inc. |
| Price-to-Sales Ratio (TTM) | 39.35 | 0.07 | Walgreens Boots Alliance Inc. |
| Enterprise Value | $10.35M | $39.67B | Walgreens Boots Alliance Inc. |
| EV/Revenue Ratio | 23.97 | 0.26 | Walgreens Boots Alliance Inc. |
| Gross Profit Margin (TTM) | 144.52% | 16.69% | Scienture Holdings Inc. |
| Revenue per Share (TTM) | $0 | $179 | Walgreens Boots Alliance Inc. |
| Earnings per Share (Diluted) | $-2.70 | $-7.29 | Scienture Holdings Inc. |
| Beta (Stock Volatility) | N/A | 0.77 | N/A |
| Short % of Float | 6.58% | 3.58% | Walgreens Boots Alliance Inc. |
Scienture Holdings Inc. vs Walgreens Boots Alliance Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Scienture Holdings Inc. | -4.68% | 2.86% | -10.00% | -20.00% | -34.55% | -30.77% |
| Walgreens Boots Alliance Inc. | 0.00% | -1.72% | 3.01% | 7.06% | 11.86% | 11.86% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Scienture Holdings Inc. | -64.49% | -92.05% | -99.44% | -97.30% | -98.31% | -98.31% |
| Walgreens Boots Alliance Inc. | 29.51% | -66.03% | -67.53% | -86.30% | -57.67% | -73.45% |
Performance & Financial Health Analysis: Scienture Holdings Inc. vs Walgreens Boots Alliance Inc.
| Metric | SCNX | WBA |
|---|---|---|
| Market Information | ||
| Market Cap | $16.98M | $10.35B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 558,906 | 64,181,498 |
| 90 Day Avg. Volume | 1,077,802 | 25,867,349 |
| Last Close | $0.36 | $11.98 |
| 52 Week Range | $0.24 - $2.60 | $8.08 - $13.25 |
| % from 52W High | -86.14% | -9.58% |
| All-Time High | $174.00 (Mar 23, 2020) | $97.30 (Aug 03, 2015) |
| % from All-Time High | -99.79% | -87.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -1.29% | 0.07% |
| Quarterly Earnings Growth | -4.18% | 0.07% |
| Financial Health | ||
| Profit Margin (TTM) | 0.77% | -0.04% |
| Operating Margin (TTM) | 18.70% | 0.01% |
| Return on Equity (TTM) | -0.56% | -0.70% |
| Debt to Equity (MRQ) | 0.03 | 409.88 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.73 | $8.30 |
| Cash per Share (MRQ) | $0.16 | $0.96 |
| Operating Cash Flow (TTM) | $-13,379,683 | $1.58B |
| Levered Free Cash Flow (TTM) | $-362,075 | $4.52B |
| Dividends | ||
| Last 12-Month Dividend Yield | 151.52% | 4.39% |
| Last 12-Month Dividend | $1.50 | $0.50 |
Valuation & Enterprise Metrics Analysis: Scienture Holdings Inc. vs Walgreens Boots Alliance Inc.
| Metric | SCNX (Apr 24, 2026) | WBA (Sep 14, 2025) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.56 | 27.10 |
| Forward P/E | -1.99 | 8.15 |
| PEG Ratio | -1.99 | -0.18 |
| Price to Sales (TTM) | 39.35 | 0.07 |
| Price to Book (MRQ) | 0.24 | 1.44 |
| Market Capitalization | ||
| Market Capitalization | $16.98M | $10.35B |
| Enterprise Value | $10.35M | $39.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 23.97 | 0.26 |
| Enterprise to EBITDA | -0.66 | 13.10 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.77 |
| Book Value per Share (MRQ) | $1.73 | $8.30 |
Financial Statements Comparison: Scienture Holdings Inc. vs Walgreens Boots Alliance Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SCNX (2025) | WBA (2024) |
|---|---|---|
| Revenue/Sales | 431,609 | 147.66B |
| Cost of Goods Sold | 100,127 | 121.13B |
| COGS % of Revenue | 23.2% | 82.0% |
| Gross Profit | 331,482 | 26.52B |
| Gross Margin | 76.8% | 18.0% |
| Research & Development | 1.96M | N/A |
| Operating Income (EBIT) | -16.24M | -1.59B |
| Operating Margin | -3,763.8% | -1.1% |
| EBITDA | -15.50M | 1.42B |
| EBITDA Margin | -3,592.1% | 1.0% |
| Pre-Tax Income | -43.51M | -14.22B |
| Pre-Tax Income % of Revenue | -10,080.2% | -9.6% |
| Income Tax | -1.99M | 1.25B |
| Income Tax % of Revenue | -462.2% | 0.8% |
| Net Income (Profit) | -41.51M | -15.45B |
| Profit Margin | -9,618.0% | -10.5% |
Balance Sheet & Liquidity Metrics
| Metric | SCNX (2025) | WBA (2024) |
|---|---|---|
| Cash & Equivalents | 6.66M | 1.32B |
| Total Current Assets | 7.92M | 18.34B |
| Total Current Assets % of Revenue | 1,834.2% | 12.4% |
| Total Current Liabilities | 2.74M | 26.95B |
| Total Current Liabilities % of Revenue | 633.8% | 18.3% |
| Long-Term Debt | 0 | 28.97B |
| Long-Term Debt % of Revenue | 0.0% | 19.6% |
| Total Shareholders Equity | 70.12M | 12.18B |
| Retained Earnings | -80.55M | 23.35B |
| Retained Earnings % of Revenue | -18,663.0% | 15.8% |
| Property, Plant & Equipment | 38,860 | 20.34B |
Cash Flow Statement Comparison
| Metric | SCNX (2025) | WBA (2024) |
|---|---|---|
| Operating Cash Flow | -36.30M | -11.75B |
| Operating Cash Flow % of Revenue | -8,409.4% | -8.0% |
| Capital Expenditures | 0 | -483.00M |
| Free Cash Flow | -13.38M | -363.00M |
| FCF Margin | -3,100.0% | -0.2% |
| Debt Repayment | -9.78M | -30.47B |
| Common Stock Repurchase | N/A | -69.00M |
Short Interest & Institutional Ownership Analysis
| Metric | SCNX | WBA |
|---|---|---|
| Shares Short | 2.22M | 22.60M |
| Short Ratio | 0.29 | 3.35 |
| Short % of Float | 6.58% | 3.58% |
| Shares Outstanding | 40.63M | 864.00M |
| Float Shares | 32.79M | 716.44M |
| % Held by Insiders | 21.88% | 17.44% |
| % Held by Institutions | 3.72% | 60.94% |
| % Held by Public | 74.40% | 21.62% |
Dividend Analysis & Yield Comparison: Scienture Holdings Inc. vs Walgreens Boots Alliance Inc.
| Metric | SCNX | WBA |
|---|---|---|
| Last 12-Month Dividend | $1.50 | $0.50 |
| Last 12-Month Dividend Yield | 151.52% | 4.39% |
| 3-Year Avg Annual Dividend | $3.17 | $1.29 |
| 3-Year Avg Dividend Yield | 44.93% | 1.75% |
| 3-Year Total Dividends | $9.50 | $3.88 |
| Ex-Dividend Date | Jul 19, 2024 | Nov 18, 2024 |